SMURF 2 (SMURF2) Human Gene Knockout Kit (CRISPR)

CAT#: KN210866

SMURF2 - human gene knockout kit via CRISPR, HDR mediated




 HDR-mediated knockout kit validation

  See Other Versions

CNY 12,260.00


货期*
4周

规格
    • 1 kit

Cited in 2 publications.

Product images

经常一起买 (3)
pCAS-Scramble, pCas-Guide vector with a scrambled sequence as a negative control (10 µg)
    • 10 ug

CNY 3,710.00


SMURF2 mouse monoclonal antibody, clone OTI3E4 (formerly 3E4)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


SMURF2 (Myc-DDK-tagged)-Human SMAD specific E3 ubiquitin protein ligase 2 (SMURF2)
    • 10 ug

CNY 5,480.00
CNY 5,800.00

Specifications

Product Data
Format 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control
Donor DNA GFP-puro
Symbol SMURF 2
Locus ID 64750
Kit Components

KN210866G1, SMURF 2 gRNA vector 1 in pCas-Guide CRISPR vector, Target Sequence: CCCGTCAAGCTGCGCCTGAC

KN210866G2, SMURF 2 gRNA vector 2 in pCas-Guide CRISPR vector, Target Sequence: GGGCCCGTTCCTCCGGCCTC

KN210866-D, donor DNA containing left and right homologous arms and GFP-puro functional cassette.

pUC vector backbone in gray; Left arm sequence in blue; GFP-puro in green; Right arm in violet

ACCCTCGGCG GCAGCTCACA CCCTCCCTGA CTGCCGGTGC CCGCCAGGGC ACCCTGCGCG CGCCCGCCGG CCCCGCCCCG GCCCCGCCCC GCCCCGCCGG CCCCGCCTCC CGTCTCCTCC CCGCCCCCCG GAGCCGACGA GTGGCGGCGG CGGCCCCAGG TCCCGGGTCC CTCAGACAAG AGGGCGGGTG GAGGAGGAAG CGGCCGAGCC CAGAGTTCTG CTCCGGCGCC CCCGAGCACC GCCCGCTTCA GCCGACCAGC CCCGTCGGCT ACTGGGCCTC GCCGAGACGA GAGGAGGGAA AGGCCTCGGC GGCCGCGAGG AGGCGGCGGG GGCGCGGGCG GAGGCGGCGC GGGCGGCCGC GGCTGCCGCT TTGTTGTGCG GCCCGGGCCG AGGAAGGAGA AGTGGGAGGA GGGGGGAGCT CGGCGTCCCG CTCCCTCCGC GGCTCATGGC GACGACTCTC GGCACATCCG GGACCCTCCG GCCGTGGCGG CCGAGGCGCC GGCTGCTCGG GCCCCAGCCC CGGCCGCTGT GGTGACTCCG CCGCGCCTCG CCGTCGCCCC CGTGCCGCCC GCCGCCCCCG CCGCCCCCGC CGCCGGGGAC GTGGGCGAGC TGGCGGGGGG TGCCTGTGGC CTTGGGAAGG GCCAGGGTCG CGATCAATGA TGAGTTGGGG GTCGGAGGAA TGGGAAGGCC TAGTTCAGGG AGAGTAATTG GAAAACCACT TGCTCTGGTT TGGACATTGT TTAAAAAGCC GAGGATGACT CGGGGCGGGG GGTGGTGTTT TGTGGAGGGG AGAATACACC GGTTCGCATC GCAGGCGGAT TTCAGGTCGG AAAGTCTTGG TCAAGGAGCC AGACGCTGCC TCCCGGGGCT CGGGGAACAG CCCCTGGGCT ACCGCCCAGG TGAGATCGTG AAGGGGATGA AGAGCTCCCG TGGCGAGGAT TATTGAATCC GGTTGCTGAC TGCGCGCAGT AAACACTCCT TAAAGATGGA GCGCTTAACG GGAGGGTGTG CGTGTGTGTT CCCGGGTTGT TACCTTGCAC ACACCCAGTT ATGCCCGCAT GAAAAACCTT TACTCCCCGC CGCCGGCCAC CGCTGCCCGG GCCACACACC TTAAACTCAT GTCTCTGAGG TGAGGAGACA GGTTGACTTT TCCGGTGTGC CTGTCTGATC CGACGGCTTG GGCTCATTGT ACACTGTGTT

GE100003, scramble sequence in pCas-Guide vector

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.
Reference Data
RefSeq NM_022739
Synonyms DKFZp686F0270; MGC138150
Summary E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Interacts with SMAD1 and SMAD7 in order to trigger their ubiquitination and proteasome-dependent degradation. In addition, interaction with SMAD7 activates autocatalytic degradation, which is prevented by interaction with SCYE1. Forms a stable complex with the TGF-beta receptor-mediated phosphorylated SMAD2 and SMAD3. In this way, SMAD2 may recruit substrates, such as SNON, for ubiquitin-mediated degradation. Enhances the inhibitory activity of SMAD7 and reduces the transcriptional activity of SMAD2. Coexpression of SMURF2 with SMAD1 results in considerable decrease in steady-state level of SMAD1 protein and a smaller decrease of SMAD2 level.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (2)

Documents

Other Versions

Customer Reviews 
Loading...